Stralem & Co’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Stralem & Co's AMGN Position: Q1 2018 in Review
Stralem & Co sold out of Amgen (AMGN) in Q1 2018, closing a stake of 70,135 shares — an estimated $12.2M sold.
Stralem & Co first reported a position in AMGN in Q3 2013 and held it in 18 quarters. The position peaked at $77.2M in Q2 2014. 1,749 funds tracked by Wall St. Rank hold AMGN as of Q1 2018.
- Stralem & Co reported no remaining Amgen position as of Q1 2018 after selling out during the quarter.
- Stralem & Co sold 70,135 Amgen shares in Q1 2018, an estimated $12.2M.
- Stralem & Co first reported a position in Amgen in Q3 2013 and held it in 18 quarters.
- Stralem & Co's Amgen position peaked at $77.2M in Q2 2014.
- 1,749 funds tracked by Wall St. Rank held Amgen as of Q1 2018.
Based on Stralem & Co's 13F filing for Q1 2018, filed 19 Apr 2018.